Does VILDAGLIPTIN Cause Interstitial lung disease? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Interstitial lung disease have been filed in association with VILDAGLIPTIN. This represents 0.8% of all adverse event reports for VILDAGLIPTIN.
16
Reports of Interstitial lung disease with VILDAGLIPTIN
0.8%
of all VILDAGLIPTIN reports
2
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From VILDAGLIPTIN?
Of the 16 reports, 2 (12.5%) resulted in death, 5 (31.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VILDAGLIPTIN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does VILDAGLIPTIN Cause?
Pemphigoid (495)
Hypoglycaemia (121)
Acute kidney injury (120)
Blood glucose increased (98)
Lactic acidosis (98)
Malaise (87)
Dyspnoea (84)
Drug ineffective (82)
Vomiting (72)
Diabetes mellitus (69)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which VILDAGLIPTIN Alternatives Have Lower Interstitial lung disease Risk?
VILDAGLIPTIN vs VILOXAZINE
VILDAGLIPTIN vs VIMPAT
VILDAGLIPTIN vs VIMSELTINIB
VILDAGLIPTIN vs VINBLASTINE
VILDAGLIPTIN vs VINCRISTINE